Kasvaja: erinevus redaktsioonide vahel
Eemaldatud sisu Lisatud sisu
P Näpukaparandusi |
Resümee puudub |
||
47. rida:
Parenhüümi moodustavad nn kasvajarakud ehk kasvajaliselt vohava koe rakud. Parenhüüm on aluseks kasvaja histoloogilisel klassifikatsioonil.
=== Strooma ===
Strooma on kasvaja toeks ja selle moodustavad [[veresoon]]erikkad ning [[lümfisoon]]i ja [[närv]]e sisaldavad kiudsidekoed. Strooma on sageli infiltreeritud ka [[lümfotsüüt]]ide ja plasmarakkudega.<ref name="HYPMd" />
Kasvaja konsistents sõltub parenhüümi ja strooma vahekorrast.
== Kasvaja nekrotiseerumine ==
Pahaloomuliste kasvajate kasv on nii kiire, et tihti ei jõua verevarustus kasvajarakke vajalike toitainetega varustada ning seetõttu tekib pahaloomulistes kasvajates [[nekroos]]. Esineb mitmesuguseid kasvaja nekroosi tüüpe: kasvajarakkude kokkupuutel väliskeskkonnaga ja võimaliku anaeroobse infektsiooniga tekib kasvajas ja elundis [[gangreen]] (nt emakavähi korral), nekroosi välja murdumisel kasvajast tekib kasvaja [[haavandumine]], õõneselundis tekib [[mulgustus]], näärmekasvajates (nt [[rinnavähk]], [[eesnäärmevähk]]) tekib [[komedonekroos]].<ref name="uMjuR" />
Healoomulised kasvajad ei nekrotiseeru.
66. rida:
Tänapäeval on selge, et madude kõikide tuvastatud anatoomilis-füsioloogiliste süsteemide rakud on võimelised erinevat tüüpi [[uudismoodustis]]i (97, neist 68 pahaloomulisi kasvajaid) komplekteerima.<ref name="bPFGd" />. Esineb [[adenokartsinoom]]e (nt [[maks]]as), [[sarkoom]]e (fibro-, lümfi-, silelihase- jms) ja pahaloomulisi [[melanoom]]e.
Kasvajate [[metastaseerumine]] maolistel on enamalt jaolt lümfo- ja hematogeenne, osad uudismoodustised on võimelised pahaloomuliste kasvajate geneesiks ka liikide vahel (indutseeritud ''tumorigenesis''-kanadel).
Kõige sagedamini on maolistel ([[boalased]], ''[[Colubridae]]'', [[mürknastiklased]], [[rästiklased]]) diagnoositud lümfisõlmede pahaloomulisi kasvajaid ([[lümfosarkoom]]i), näiteks [[egiptuse kobra]]l, ''[[Lampropeltis getulus getulus]]''<nowiki>'</nowiki>el, ''[[Bitis nasicornis]]''<nowiki>'</nowiki>el ja lümfisõlmedesse [[metastaas|metastaseerunud]] pahaloomulisi kasvajaid ([[roheline anakonda|rohelisel anakondal]] (1969)) jpt.<ref name="
===Kasvaja rakuliinid teaduses===
86. rida:
{{viited|allikad=
<ref name="j3OJt">"[[Meditsiinisõnastik]]" 333:2004.</ref>
<ref name="pmy0T">[[Ingrid Mesila]], [[Enn Jõeste]], [[Mari-Ann Reintam]], [[Hannes Tamm]], [[Živile Riispere]], [[Maret Murde]], [[Retlav Roosipuu]], "Patoanatoomia õpik kõrgkoolile",
<ref name="gGPFM">Peeter Padrik, Hele Everaus, "Onkoloogia õpik Arstiteaduskonna 4. kursusele", lk 7, 2013, Tartu Ülikooli Kirjastus OÜ, ISBN: 9789949323067.</ref>
<ref name="eC8Jm">
<ref name="R1KIF">
<ref name="HYPMd">
<ref name="uMjuR">
<ref name="YXRKO">H.G.Schlumberger, B.Lucke, [http://www.archive.org/stream/tumorsoffishesam00schluoft#page/n3/mode/2up "Tumors of Fishes, Amphibians and Reptiles"], Cancer Research, Vol 8, Nr 12, Detsember
<ref name="bPFGd">H.E.Kaiser,[http://link.springer.com/book/10.1007/978-94-009-1091-1/page/1 "Comparative Aspects of Tumor Development"] Cancer Growth and Progression, Vol 5, 1989, DOI 10.1007/978-94-009-1091-1_3, ISBN 978-94-010-6981-6
<ref name="RGxbG">Werner Frank, Arwid Schepky, [http://vet.sagepub.com/content/6/5/437.abstract "Metastasierendes Lymphosarkom bei einer Riesenschlange, Eunectes murinus (Linnaeus, 1758)"] doi: 10.1177/030098586900600507 Veterinary Pathology September 1969 vol. 6 no. 5 437–443, Osaline
<ref name="hEh8m">[http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM319573.pdf Cell Lines Derived from Human Tumors for Vaccine Manufacture], FDA Briefing Document, Vaccines and Related Biological Products Advisory Committee Meeting, September 19, 2012,
▲<ref name="RGxbG">Werner Frank, Arwid Schepky, [http://vet.sagepub.com/content/6/5/437.abstract "Metastasierendes Lymphosarkom bei einer Riesenschlange, Eunectes murinus (Linnaeus, 1758)"] doi: 10.1177/030098586900600507 Veterinary Pathology September 1969 vol. 6 no. 5 437–443, Osaline veebiversioon (vaadatud 31.08.2013)<small> (''inglise keeles'')</small></ref>
<ref name="Ah81w">[http://www.lgcstandards-atcc.org/products/all/TIB-161.aspx?geo_country=ee#generalinformation HuT 78 (ATCC® TIB-161™)],
▲<ref name="hEh8m">[http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM319573.pdf Cell Lines Derived from Human Tumors for Vaccine Manufacture], FDA Briefing Document, Vaccines and Related Biological Products Advisory Committee Meeting, September 19, 2012, veebiversioon (vaadatud 17.05.2014)<small> (''inglise keeles'')</small></ref>
<ref name="j3spx">Lisa M. Johansen, Jennifer M. Brannan, Sue E. Delos, Charles J. Shoemaker, Andrea Stossel, Calli Lear, Benjamin G. Hoffstrom, Lisa Evans DeWald, Kathryn L. Schornberg, Corinne Scully, Joseph Lehár, Lisa E. Hensley, Judith M. White, ja Gene G. Olinger, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955358/ FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection], Sci Transl Med. Jun 19, 2013; 5(190): 190ra79., doi: 10.1126/scitranslmed.3005471, PMCID: PMC3955358, NIHMSID: NIHMS559803,
▲<ref name="Ah81w">[http://www.lgcstandards-atcc.org/products/all/TIB-161.aspx?geo_country=ee#generalinformation HuT 78 (ATCC® TIB-161™)], veebiversioon (vaadatud 17.05.2014)<small> (''inglise keeles'')</small></ref>
▲<ref name="j3spx">Lisa M. Johansen, Jennifer M. Brannan, Sue E. Delos, Charles J. Shoemaker, Andrea Stossel, Calli Lear, Benjamin G. Hoffstrom, Lisa Evans DeWald, Kathryn L. Schornberg, Corinne Scully, Joseph Lehár, Lisa E. Hensley, Judith M. White, ja Gene G. Olinger, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955358/ FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection], Sci Transl Med. Jun 19, 2013; 5(190): 190ra79., doi: 10.1126/scitranslmed.3005471, PMCID: PMC3955358, NIHMSID: NIHMS559803, veebiversioon (vaadatud 20.09.2014)<small> (''inglise keeles'')</small></ref>
}}
==Välisallikad==
* M. M. Garner, [http://www.ivis.org/proceedings/acvp/2004/garner/ivis.pdf Trends in Reptilian Neoplasia: a Diagnostician’s Perspective], (13. nov 2004), 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP (Eds.),
* C. S. Muir, C. Percy, [http://www.iarc.fr/en/publications/pdfs-online/epi/sp95/sp95-chap7.pdf Chapter 7. Classification and coding of neoplasms],
* Lynn E Heasley, [http://www.nature.com/onc/journal/v20/n13/full/1204183a.html Autocrine and paracrine signaling through neuropeptide receptors in human cancer], 26. märts 2001, 20.köide , number 13, lk 1563–1569,
* Christopher D.M. Fletcher, K. Krishnan Unni, Fredrik Mertens, World Health Organization Classification of Tumours, [http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb5/BB5.pdf Pathology and Genetics of Tumours of Soft Tissue and Bone], IARC Press, Lyon, 2002,
* [http://www.iarc.fr/en/publications/pdfs-online/wcr/2003/wcr-3.pdf Mechanisms of tumour development],
* Alo Lõhmus, [http://tarbija24.postimees.ee/184700/rinnavahk-osutus-arvatust-kavalamaks Rinnavähk osutus arvatust kavalamaks], 06. november 2009,
* Ewa M. Michalak, Cassandra J. Vandenberg, [...], ja Andreas Strasser,
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912558/ Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death], Genes Dev. 1. august 2010; 24(15): 1608–1613.,
* Ahmedin Jemal, Freddie Bray, Melissa M. Center, Jacques Ferlay, Elizabeth Ward, David Forman, [http://onlinelibrary.wiley.com/doi/10.3322/caac.20107/pdf Global Cancer Statistics], 61.köide, nr 2, 4 veebruar 2011, CA: A Cancer Journal for Clinicians,
* Virna Cortez-Retamozoa, Martin Etzrodta, Andita Newtona, Philipp J. Raucha, Aleksey Chudnovskiya, Cedric Bergera, Russell J. H. Ryanb, Yoshiko Iwamotoa, Brett Marinellia, Rostic Gorbatova, Reza Forghania, Tatiana I. Novobrantsevac, Victor Kotelianskyc, Jose-Luiz Figueiredoa, John W. Chena, Daniel G. Andersond, Matthias Nahrendorfa, Filip K. Swirskia, Ralph Weissledera, ja Mikael J. Pitteta, [http://www.pnas.org/content/109/7/2491.full Origins of tumor-associated macrophages and neutrophils], 109. väljaanne, nr 7, lk 2491–2496, doi: 10.1073/pnas.1113744109,
* Beata Ujvari, Anne-Maree Pearse, Sarah Peck1, Collette Harmsen, Robyn Taylor, Stephen Pyecroft, Thomas Madsen, Anthony T. Papenfuss ja Katherine Belov, [http://rspb.royalsocietypublishing.org/content/early/2012/11/01/rspb.2012.1720.full Evolution of a contagious cancer: epigenetic variation in Devil Facial Tumour Disease], 7. november 2012 , doi:10.1098/rspb.2012.1720, Proc. R. Soc. B rspb20121720,
* Joseph W. Nichols ja You Han Bae, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519442/ Odyssey of a cancer nanoparticle: from injection site to site of action], Nano Today. 1. detsember 2012 ; 7(6): 606–618., doi:10.1016/j.nantod.2012.10.010, PMCID: PMC3519442, NIHMSID: NIHMS422777,
* Michael R Shurin, Viktor Umansky, Anatoli Malyguine, [https://books.google.ee/books?id=hcNEAAAAQBAJ&pg=PA250&lpg=PA250
* California Institute for Regenerative Medicine, [http://cirmresearch.blogspot.com/2014/04/tumor-cells-become-drug-resistant-by.html Tumor Cells Become Drug Resistant by Reverting to a Stem Cell-Like State, New Study Finds], 23. aprill 2014,
; Lümfoidkoe kasvajad
* Elaine S. Jaffe, Nancy Lee Harris, [...], ja Peter G. Isaacson, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954680/ Classification of lymphoid neoplasms: the microscope as a tool for disease discovery], Blood. 1. detsember 2008 ; 112(12): 4384–4399., doi:
* Elias Campo, Steven H. Swerdlow, [...], ja Elaine S. Jaffe, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109529/ The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications], Blood. 12. mai 2011; 117(19): 5019–5032.
; Rakkude senestsents kasvajas
* Manuel Collado and Manuel Serrano, [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672965/ Senescence in tumours: evidence from mice and humans], Nat Rev Cancer. jaanuar 2010; 10(1): 51–57. doi: 10.1038/nrc2772, PMCID: PMC3672965, EMSID: EMS51925,
; Roomajatel:
*K.O.Heckers, H.Aupperle, V.Schmidt, M.Pees, [http://www.laboklin.de/pdf/en/publications/2011_j_comp_pathol_08_melanophorma.pdf Melanophoromas and Iridophoromas in Reptiles], Journal of Comparative Pathology (2011),
; Kutsekasvaja
| |||